Friday - April 4, 2025
Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million
March 07, 2025
PALO ALTO, California, March 7 -- Cooley, a law firm, issued the following news release:

* * *

Chimerix Announces Acquisition by Jazz Pharmaceuticals for $935 Million

New York - March 5, 2025 - Cooley advised Chimerix (Nasdaq: CMRX), a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, on its definitive agreement to be acquired by Jazz Pharmaceuticals (Nasdaq: JAZZ . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products